Navigation Links
Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
Date:11/4/2009

43,087 34,355 37,484 33,539 ====== ====== ====== ======

SOURCE Orexigen Therapeutics, Inc.


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...nt radiation reduction in cardiac CT scans ,, C...s Earls, a radiologist from Fairfax Radiological C...nt the findings of a study that shows a 90 percent...ts received from CT scans compared to scans perfor...the study to the annual meeting of the Radiologica...
(Date:12/1/2009)....J., Dec. 1 Former New J... delighted when his radiotherapy treatment session...ach day to less than five. Midway through his cou...Urology Cancer Center acquired the region,s firs...rian Medical Systems (NYSE: VAR ), making it pos...
(Date:12/1/2009)...c. 1 Cumberland Pharmace... an independently conducted study of Acetadote ( a...cysteine, as a cost-saving treatment for acetamino...4 of the peer-reviewed Journal of Medical Economi...s that Acetadote is a less costly treatment regime...
Breaking Medicine Technology:Radiation Reduction in Heart CT Scans Reported in Study 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6Frutarom Launches New Global Branding 5437 1Frutarom Launches New Global Branding 5437 2Frutarom Launches New Global Branding 5437 3Sangamo Announces Closing of Common Stock Offering 5433 1Sangamo Announces Closing of Common Stock Offering 5433 2Sangamo Announces Closing of Common Stock Offering 5433 3Bioluminescence imaging used for eye cancer detection 59379 1Bioluminescence imaging used for eye cancer detection 59379 2
...h Kogenate FS Reduces the,Risk of Joint Damage and...Joint Damage, BERKELEY, Calif., Oct. 10 Bayer He...d Drug Administration (FDA) has,approved routine p...or,(Recombinant) to reduce the frequency of bleedi...ts aged 0-16 years with severe hemophilia A with n...
...orporation (NYSE: BSX ) today announced the sched...cements at the Cardiovascular Research Foundation,...lar Therapeutics (TCT),scientific symposium, which...Boston Scientific will be announcing a wide range ...s2(TM) and second-generation TAXUS(R),Liberte(R) P...
Other Medicine Technology:FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6
(Date:12/1/2009)... , LOS ANGELES, Dec. 1 A dec...ational Labor Relations Board (NLRB) has put at ri... pensions of Kaiser Permanente RNs, social workers..."We have worked for years to achieve standards at ...de the professional care our patients need," said ...
(Date:12/1/2009)...centa accreta is increasingly common but more easi...Dec. 1 (HealthDay News) -- A magnetic resonance i...e-threatening pregnancy complication called placen... occurs when the placenta surrounding a fetus atta...ry, the placenta can pull out parts of the uterine...
(Date:12/1/2009)...OUSTON - Using routine computed tomography (CT) im...lorectal liver metastasis after bevacizumab and ch... to research from The University of Texas M. D. An...ed in the Dec. 2 issue of JAMA . , When combine...vacizumab, also known as Avastin, is associated wi...
(Date:12/1/2009)... , NEW ORLEANS, Dec. 1 /PRNewswire-USNe...) will host its annual High School Student Symposi...er 3, at 8:00 a.m. CST. The symposium, which encou...iences, and medical research, is held in conjuncti...ar, students will have the opportunity to explore ...
(Date:12/1/2009)... , NEW ORLEANS, Dec. 1 /PRNewswire-USNews... the world,s largest professional association of b...es at the 51st ASH Annual Meeting from December 5-... in New Orleans, LA. The meeting will showcase the...s. ,, "It is my pleasure to host ASH,s 51st an...
Breaking Medicine News(10 mins):Health News:Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy 2Health News:Serious Pregnancy Complication Detected With MRI 2Health News:CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 2Health News:CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 3Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3
... with prostate cancer who have their prostate remo...e effect after surgery, but urinary dysfunction tr...f Florida researcher. Whats more, many arent emoti...re practitioners to educate their patients about t...
... CALL DATE: Wednesday, Feb. 27, 2008 ... HOST: Dr. Candace Kendle, Chairman and ...one conference call and,simultaneous webcast Feb. ...follow., (Logo: http://www.newscom.com/cgi-bin/p...
...to silence union activist, CHICAGO, Jan. 30 Regi... has issued an unfair labor practice complaint,aga... to silence a union,supporter at West Suburban Med...r speak to his coworkers in the Food Service,depar...
...in Relief Alternative To Prescription and ...GELES, Jan. 30 One in ten Americans report,suffer...nd debilitating,arthritis. Most often, pain suffer... to educate consumers about pain,relieving alterna...
...30 Expanding the,pipeline of HIV prevention tools... Microbicides (IPM) today announced that Pfizer In...license to maraviroc, its,newly-approved HIV treat...ntiretroviral drugs known as CCR5 blockers, which,...
...30, 2007 Aggression, testosterone and nepotism do...ut the support of a good female can, according to ...rican species of fish. , The study, published tod...ics. , We found that changes in social status w...
Other Medicine News:Health News:Urinary dysfunction troubles men who undergo prostate removal 2Health News:Urinary dysfunction troubles men who undergo prostate removal 3Health News:Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast 2Health News:Labor Board Issues Complaint Against Resurrection Health Care 2Health News:Photos: Niavin Corporation Offers Pain Sufferers a New Way to Address Pain 2Health News:IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide 2Health News:IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide 3Health News:Females decide whether ambitious males float or flounder 2
Akbarnia PDR
Spinal Instruments
Autologous Growth Factors
Leica D2D V3
Medicine Products: